文献速递乳腺MR乳腺X线

Meta分析:放射状瘢痕与乳腺MRI

Meta-analysis: Radial Scar and Breast MRI.
PubMed 文献 · Acad Radiol · 2024-05-07

该系统综述与Meta分析检索MEDLINE和EMBASE数据库,评估乳腺对比增强MRI在钼靶检出放射状瘢痕中的获益,主要终点为MRI表现与最终结局(单纯放射状瘢痕 versus 放射状瘢痕伴不典型增生或恶性)的相关性;共纳入3项研究,每项研究的阴性预测值均为100%;作者认为高阴性预测值可能允许在MRI阴性时推迟活检、改为短期影像随访。

要点

  • 钼靶检出放射状瘢痕时,乳腺对比增强MRI阴性者的阴性预测值在纳入的每项研究中均为100%。
  • 作者认为MRI阴性时可能可推迟活检、改为短期影像随访。
  • 该结论基于仅3项研究的系统综述与Meta分析。

核心结论

  • 乳腺对比增强MRI在钼靶检出放射状瘢痕时具有高阴性预测值,每项纳入研究的阴性预测值均为100%。
  • 作者认为该高阴性预测值可能允许在MRI阴性时推迟活检、改为短期影像随访。

研究设计与样本

  • 系统综述与Meta分析,检索MEDLINE和EMBASE数据库,检索于2022年进行。
  • 依据PRISMA指南进行分析。
  • 共纳入3项研究。
  • 主要终点为乳腺对比增强MRI表现与放射状瘢痕最终结局(单纯放射状瘢痕 versus 放射状瘢痕伴不典型增生或恶性)之间的相关性。

诊断标准与关键数值

  • 每项纳入研究的阴性预测值均为100%,用于排除放射状瘢痕伴不典型增生或恶性。

临床应用与阅片要点

  • 作者认为,在乳腺对比增强MRI阴性的放射状瘢痕病例中,高阴性预测值可能允许推迟活检、改为短期影像随访。

局限性

  • 仅3项研究可用。
  • 关于不典型增生与乳腺对比增强MRI的数据很少。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND: The implementation of digital breast tomosynthesis has increased the detection of radial scar (RS). Managing this finding may be experienced as a clinical dilemma in daily practice. Breast Contrast-Enhanced MRI (CE-BMR) is a known modality in case of problem-solving tool for mammographic abnormalities. However, the data about AD and CE-BMR are scant.

OBJECTIVE: The purpose was to estimate the benefit of CE-BMR in the setting of RS detected mammographically through a systematic review and meta-analysis of the literature.

METHODS: A search of MEDLINE and EMBASE databases were conducted in 2022. Based on the PRISMA guidelines, an analysis was performed. The primary endpoint was the correlation between CE-BMR findings and definite outcome for RS (pure RS versus RS associated with atypia or malignancy).

RESULTS: Three studies were available. The negative predictive value (NPV) was 100% for each.

CONCLUSION: The high NPV could allow for deferral of a biopsy in favor of a short-interval imaging follow-up in the setting of a negative CE-BMR.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. Ferre R, Covington MF, Kuzmiak CM, et al. Meta-analysis: Radial Scar and Breast MRI. Acad Radiol. 2024. PMID: 38714429. doi:10.1016/j.acra.2024.04.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。